TGF-beta pathway and inflammatory biomarkers across HFpEF and PAH patients

9 May 2026 (08:00 - 12:45)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Ms Carolina Janssen Telders

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

6 More presentations in this session

Presentation thumbnail

Single-cell transcriptomics uncovers immune remodeling in heart failure complicated by myocarditis

Doctor M. Liu (Xi'an, CN)

Abstract Slides

Presentation thumbnail

Early changes in NLPR3 after a heart failure hospitalization and subsequent clinical outcomes in patients with heart failure and preserved ejection fraction

Doctor E. Santiago-Vacas (Badalona, ES)

Abstract Slides

Presentation thumbnail

Elevated hsCRP unmasks a distinct metabolic-inflammatory HFpEF phenotype

Ms E. Verghote (Maastricht, NL)

Abstract Slides

Presentation thumbnail

Resource and knowledge gaps drive limited assessment of inflammation, leading to diagnostic and treatment delays in heart failure patients: findings from Brazil, Israel, and Saudi Arabia

Doctor O. Caspi (Haifa, IL)

Abstract Slides

Presentation thumbnail

Beyond hemodynamics: LVEF as a master regulator of the systemic inflammatory response

Miss G. Martinez Gonzalez (MX)

Abstract Slides

Access the full session

Session thumbnail

Inflammation: the fire behind heart failure?

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026

You may be interested in

Congress Presentation

Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.

Congress Session

Clinical phenotypes of heart failure with preserved ejection fraction

Congress Presentation

Mitral regurgitation, atrial fibrillation, and HFpEF: a three-headed dragon

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources